The identification of a specific
biomarker involves the development of new clinical diagnostic tools, and an in-depth understanding of the disease at the molecular level. When new blood vessels form in
tumor cells, endothelial cell production is induced, a process that plays a key role in
disease progression and
metastasis to distinct organs for solid
tumor types. The present study reports on the identification of a new
biomarker on primary cultured mouse
tumor endothelial cells (mTECs) using our recently developed high-affinity
DNA aptamer AraHH001 (Kd = 43 nmol/L) assisted proteomics approach. We applied a strategy involving aptamer-facilitated
biomarker discovery.
Biotin-tagged AraHH001 was incubated with lysates of mTECs and the aptamer-
proteins were then conjugated with
streptavidin magnetic beads. Finally, the bound
proteins were separated by sodiumdodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with
silver staining. We identified
troponin T via matrix assisted
laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, the molecular target of aptamer AraHH001, and its presence was confirmed by measuring
mRNA,
protein levels, western blot, immunostaining, a gel shift assay of AraHH001 with
troponin T. We first report here on the discovery of
troponin T on mTECs, a promising and interesting diagnostic tool in the development of antiangiogenic
therapy techniques the involves the targeting of the
tumor vasculature.